Fingerprint
Dive into the research topics of 'Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically